Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial-Reference-Cited by-同舟云学术

Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial

Published:1998-06 Issue:3 Volume:49 Page:209-217
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Amadori Dino,Frassineti Giovanni Luca,De Matteis Andrea,Mustacchi Giorgio,Santoro Antonio,Cariello Salvatore,Ferrari Massimo,Nascimben Ottorino,Nanni Oriana,Lombardi Alessandra,Scarpi Emanuela,Zoli Wainer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/A:1006063412726

Reference50 articles.

1. Tormey DC: Adriamycin in breast cancer. Cancer Chemother Rep (Part 3) 6: 319–327, 1975

2. Jain KK, Casper ES, Geller NL, Hakes TB, Kaufman RJ, Curric V, Schwartz W, Cassidy C, Petroni GR, Young CW: A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer. J Clin Oncol 3(6): 818–826, 1985

3. Perez DJ, Harvey VJ, Robinson BA, Atkinson CH, Dady PJ, Kirk AR, Evans BD, Chapman PJ: A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer. J Clin Oncol 9: 2148–2152, 1991

4. Cowan JD, Neidhart J, Mc Clure S, Coltman CA, Gumbart C, Martino S, Hutchins LF, Stephens RL, Vaughan CB, Osborne CK: Randomized trial of doxorubicin, bisanthrene, and mitoxantone in advanced breast cancer: a Southwest Oncology Group study. J Natl Cancer Inst 83: 1077–1084, 1991

5. Jones S, Durie BG, Salmon SE: Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer 36: 90–97, 1975

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance;Cancers;2023-06-28

2. Tumor Metabolism: Challenges and Future Perspectives;Handbook of Cancer and Immunology;2023

3. Overview of Cancer Metabolism and Signaling Transduction;International Journal of Molecular Sciences;2022-12-20

4. Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies;Cancers;2022-09-21

5. Probiotic-derived heptelidic acid exerts antitumor effects on extraintestinal melanoma through glyceraldehyde-3-phosphate dehydrogenase activity control;BMC Microbiology;2022-04-22